Iloprost protects the spinal cord during aortic cross-clamping in a canine model

Journal of Cardiovascular Surgery

Volumn 41, Issue 1, 2000, Pages 89-93

  Katircioglu S F ^a,c   Ulus, A T ^a   Gokce P ^b   Surucu S ^d  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Ilkiz Sok   (Turkey)

^d NONE

Author keywords

Aorta surgery; Iloprost; Ischemia prevention and control; Spinal cord blood supply

Indexed keywords

ILOPROST; PROSTACYCLIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; AORTA OCCLUSION; ARTICLE; BLOOD PRESSURE MONITORING; CELL VACUOLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOG; DRUG INFUSION; ELECTRON MICROSCOPE; INTRAOPERATIVE PERIOD; MEAN ARTERIAL PRESSURE; NEUROLOGIC EXAMINATION; NONHUMAN; PREOPERATIVE PERIOD; REPERFUSION INJURY; SCORING SYSTEM; SPINAL CORD BLOOD FLOW; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; SUBCLAVIAN ARTERY; TREATMENT OUTCOME;

ANIMALS; AORTA, ABDOMINAL; BLOOD PRESSURE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ILOPROST; ISCHEMIA; MICROSCOPY, ELECTRON; MYELIN SHEATH; REPERFUSION INJURY; SPINAL CORD; VASODILATOR AGENTS;

EID: 0034072103     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Nylander WA, Plunkett RJ, Hammon JW, Oldfield EH, Meacham WF. Thiopental modification of ischemic spinal cord injury in the dog. Ann Thorac Surg 1982;33:64-8.
2. Hao JX, Xu XJ, Aldskogius H, Seiger A, Wiesenfeld-Hallin Z. The excitatory amino acid receptor antagonist MK-801 prevents the hypersensitivity induced by spinal cord ischemia in the rat. Exp Neurol 1991;113:182-91.
3. Katircioglu SF, Küçükaksu DS, Küplülü S, Vural K, Bayazit M, Tasdemir O et al. Effects of prostacyclin on spinal cord ischemia: An experimental study. Surgery 1993;114:36.
4. Katircioglu SF, Saritas Z, Yücel D, Bayazit M, Tasdemir O, Bayazit K. Spinal cord protection with the use of prostacyclin during aortic occlusion. J Surg Res 1990;65:77-81.
5. Katircioglu SF, Saritas Z, Küçüker S, Tasdemir O, Bayazit K. Enoximone usage for experimental spinal cord protection during aortic cross-clamping. Thorac Cardiovasc Surgeon 1996;44:245.
6. Katircioglu SF, Küçükaksu DS, Bozdayi M, Saydam G, Zorlutuna Y, Tasdemir O et al. Effects of prostacyclin on heparin reversal with protamine. Vasc Surg 1992;26:464.
7. Katircioglu SF, Küçükaksu DS, Bozdayi M, Tasdemir O, Bayazit K. Beneficial effects of prostacyclin treatment on reperfusion of the myocardium. Cardiovasc Surg 1995;4:405.
8. Katircioglu SF, Gökçe P, Özgencil E, Santas Z, Sener E, Yilmazkaya B et al. Prostacyclin usage for spinal cord protection during experimental thoracic aortic cross clamping. Vasc Surg 1996;30:97.
9. Tarlow IM. Spinal cord compression: Mechanisms of paralysis and treatment. Springfield IL, Charles C Thomas, 1957:147.
10. Cuevas P, Reimers D, Carceller F, Jimenez A. Ischemic reperfusion injury in rabbit spinal cord: protective effect of superoxide dysmutase on neurological recovery and spinal infarction. Acta Anat 1990;137:303-10.
11. Coles JG, Wilson Gj, Sima AF, Klement P, Tait GA, Williams WG et al. Intraoperative management of thoracic aortic aneurysm: Experimental evaluation of perfusion cooling of the spinal cord. J Thorac Cardiovasc Surg 1983;85:292-9.
12. Elmore JR, Gloviczki P, Harper CM Jr, Murray MJ, Wu QH, Pairolew PC et al. Spinal cord injury in experimental thoracic aortic occlusion: Investigation of combined methods of protection. J Vasc Surg 1992;15:789-99.
13. Miyamoto K, Ueno A, Wada T. A new and simple method of preventing spinal cord damage following temporary occlusion of the thoracic aorta by draining the cerebrospinal fluid. J Cardiovasc Surg 1960;16:188-97.
14. Breckwoldt WI., Genco CM, Connoly RJ, Cleveland RJ, Diehl JT. Spinal cord protection during aortic occlusion: Efficacy of intrathecal tetracaine. Ann Thorac Surg 1991;51:959-63.
15. Shine T, Nugent M. Sodium nitroprusside decreases spinal cord perfusion pressure during descending thoracic aortic cross-clamping in the dog. J Cardiothorac Anest 1990;4:184-93.
16. Lim KH, Connolly M, Rose D, Siegman F, Jacobowitz I, Acinapura A et al. Prevention of reperfusion injury of the ischemic spinal cord: Use of recombinant superoxide dysmutase. Ann Thorac Surg 1986;42:282-6.
17. Le may DR, Neal S, Zelenock GJ, D'Alecy LG. Paraplegia in the rat induced by aortic cross-clamping: Model characterization and glucose exacerbation of neurologic deficit. J Vasc Surg 1987;6:383-90.
18. Fowl RJ, Pattersan RB, Gewirtz RJ, Anderson DK. Protection against postischemic spinal cord injury using a new 21-aminosteroid. J Surg Res 1990;48:597-600.
19. Grabitz K, Freye E, Prior R, Schror K, Sandmann W. Does prostaglandin E1 and superoxide dysmutase prevent ischemic spinal cord injury after thoracic aortic cross-clamping. Eur J Vasc Surg 1990;4:19-24.
20. Clark WM, Madden KP, Kothlein MF, Zivin JA. Reduction of central nervous system ischemic injury by monoclonal antibody to intracellular adhesion molecule. J Neurosurg 1991;75:623-7.
21. Faden AI, Jacobs TP, Smith MT. Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia. J Neurosurg 1984;60:796-9.
22. Grant SM, Goa KL, Iloprost. Drugs 1992;43(6):889-924.
23. Bugiardini R. Evaluation toward necrosis during intermittent periods of myocardial ischemia: cytoprotective effects of iloprost, a stable prostacyclin analogue. In: Gryglewski RJ, Stock G, editors. Prostacyclin and its stable analogue iloprost. Berlin: Springer-Verlag, 1987:215-29.
24. Ferrari R, Cargnoni A, Ceconi C, Curello S, Belloli S et al. Protective effect of a prostacyclin-mimetic on the ischaemic-reperfusion rabbit myocardium. J Moll Cell Card 1988;20:1095-106.
25. Ferrari R, Cargnoni A, Curello S, Boffa GM, Ceconi C. Effect of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts. Br J Clin Pharm 1989;98:678-81.
26. Funke K, Schrör K. Preservation of ischaemia induced loss of myocardial cathecolamines and sympathetic nerve stimulation by the synthetic prostacyclin analogue iloprost (ZK 36374). In: Schror, editor. Prostaglandins and other eicosanoids in the cardiovascular system. Proceedings of the 2nd International symposium, Nümberg-Fürth, Karger, Basel 1985:310-5.
27. Björnsson OG, Kobayashi K, Williamson JR. Interaction between leukotriene D4 and adenosine or iloprost in the isolated working guinea-pig heart: prevention of the leukotriene D4 effect. Eur J Clin Invest 1987;17:146-55.
28. Mentz P, Mest MJ, Amger H. Interaction of iloprost and indomethacin, with the cardiac effects of isoprenaline, ouabain and trapidil. Biomedica Biochimica Acta 1988;47:109-12.
29. Van Gilst WH, Boonstra PW, Terpstra JA, Wildevuur CRH, de Langen CDJ. Improved recovery of cardiac function after 24 hrs of hypothermic arrest in the isolated rat heart: comparison of a prostacyclin analogue (ZK 36374) and a calcium entry blocker (diltiazem). J Cardiovasc Pharm 1985;7:520-4.
30. Thiemermann C, Steinhagen-Thiessen E, Schrör K. Inhibition of oxygen-centered free radical formation by the stable prostacyclin-mimetic iloprost (ZK 36374) in acute myocardial ischaemia. J Cardiovasc Pharm 1984;6:365-6.
31. Belkin M, Wright JG, Hobson RW, Iloprost infusion decreases skeletal muscle ischemia-reperfusion injury. J Vasc Surg 1990;11:77-83.